WASHINGTON – The Food and Drug Administration has approved the first artificial intelligence software that can interpret images without a clinician’s involvement, the agency announced Wednesday. The software, called IDx-DR, looks for diabetic retinopathy, an eye disease that afflicts individuals with diabetes. With minimal training, healthcare providers can use a special camera to take a picture…